Lumea and Paige partner to integrate AI-powered workflows, enhancing diagnostic efficiency and accessibility in cancer care. LEHI, UT, UNITED STATES, June 3, 2025 /EINPresswire.com/ — Lumea, the U.S. leader in…
Read More
Lumea and AIxMed team up to bring AI-driven urine cytology to Lumea's platform, targeting improved bladder cancer diagnostics. LEHI, UT, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Lumea, a leading...
Read More
Lehi, Utah — May 13, 2025 — Lumea, a leader in digital pathology and workflow innovation, is pleased to announce the upcoming transition of the Chief Executive Officer role, which...
Read More
LEHI, UT, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Lumea, a leader in digital pathology solutions. AIRA Matrix Private Limited, an innovative technology company for AI-based diagnostic, prognostic, and predictive...
Read More
Lumea’s Digital Diagnostic Suite™ (Viewer+™) Receives FDA 510(k) Clearance* for Clinical Diagnosis LEHI, UTAH, UNITED STATES, March 18, 2025 /EINPresswire.com/ – Lumea, a leader in digital pathology solutions, is proud…
Lumea and Myriad Genetics have partnered to integrate Myriad’s Prolaris® and MyRisk® molecular diagnostic tests into Lumea’s BxLink™ digital pathology platform. LEHI, UT, UNITED STATES, February 5, 2025 /EINPresswire.com/ --...
Read More
